Eye Diseases

The Rotterdam Eye Hospital is active in ophthalmology research focused on a range of vision-threatening conditions. Current studies examine exudative age-related macular degeneration, neovascular age-related macular degeneration, geographic atrophy, central serous chorioretinopathy, and persistent corneal epithelial defect, with the goal of improving treatment effectiveness and patient outcomes.

  • Research includes testing new approaches for retinal disease, evaluating treatment combinations, and assessing therapies that may better preserve vision.
  • Studies also look at healing support for corneal surface disease and symptom control in chronic eye conditions.
  • The site supports clinical research aimed at both short-term improvement and longer-term disease management.

These trials reflect a strong focus on retina, macular, and corneal disorders, with an emphasis on finding safer and more effective care options.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Research at this site also covers inherited eye disease, especially conditions that affect vision from an early age or progress over time. Key studies involve retinitis pigmentosa and Stargardt disease, focusing on whether emerging therapies can slow disease progression and support retinal function.

  • Investigations are centered on inherited retinal disorders linked to genetic causes and long-term vision loss.
  • The research aims to evaluate whether new treatments can improve disease control and protect remaining sight.
  • These studies add an important genetic ophthalmology dimension to the hospital’s trial portfolio.

The work at Rotterdams Oogheelkundig Instituut highlights efforts to advance care for patients with rare, hereditary conditions where treatment options remain limited.

Specialized Vision and Ocular Surface Research

Several trials at the Rotterdam Eye Hospital focus on specific eye conditions such as acquired blepharoptosis and persistent corneal epithelial defect. These studies are designed to test new therapies that may improve eyelid function or support corneal healing more effectively than current care.

  • Research in this area includes evaluating treatments for drooping eyelids that can affect vision and daily comfort.
  • Ocular surface studies are examining ways to promote complete healing in hard-to-treat corneal defects.
  • The site’s work combines symptom relief, visual function, and tissue repair as key research goals.

Together, these studies show a broad commitment to improving both common and rare eye disorders through clinical investigation.